Given this physical juxtaposition and frequent homozygous deletion of 9p21 (approximately 40% of tumors), many PDACs sustain loss of both INK4A and ARF, thereby disrupting both the RB and p53 tumor suppression pathways. The gene discussed is TP53; the disease is neoplasm.